ANDA 206105, held by Nuvo Pharms Inc. Polyethylene Glycol 3350.
As of Nov 16, 2026, ANDA 206105 (Polyethylene Glycol 3350), held by Nuvo Pharms Inc, was first approved by FDA on Oct 28, 2016, with 1 approved supplement and 0 published complete response letters.
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Polyethylene Glycol 335017GM/SCOOPFUL · for solution;oral | Polyethylene Glycol 3350 | OTC |
| Feb 9, 2023 | Supplement 4Manufacturing | Approved | None posted |
| Oct 28, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters